The Competition Commission of India on Thursday said it has cleared Berhyanda Ltd's acquisition of a 76.10% stake in pharmaceutical firm Suven Pharmaceuticals Ltd.
Berhyanda Ltd. is a wholly-owned subsidiary of Berhyanda Midco Ltd., which is an affiliate of Advent International Corporation.
The proposed combination relates to the acquisition by Berhyanda Ltd for up to 76.10% of the voting share capital of Suven Pharmaceuticals Ltd, by way of a share purchase agreement dated December 26, 2022, and pursuant to the mandatory open offer in compliance with Sebi's SAST regulations, according to an official release.
Suven Pharmaceuticals Ltd is a biopharmaceutical company that offers its services to global pharmaceutical and agrochemical majors.
Deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices in the marketplace.
RECOMMENDED FOR YOU
Apollo Hospital Shares Fall Most In Two Years After Arm Stake Sold At Lower Valuation
Apr 29, 2024
Apollo Hospitals - Stake Sale In Apollo HealthCo + Keimed Merger, A Positive Step: Prabhudas Lilladher
Apr 29, 2024
Apollo HealthCo Secures Rs 2,475 Crore Investment From Advent International In Major Deal
Apr 26, 2024
Emirates Needs Time To Clear Flood Backlog As Clark Says Sorry
Apr 22, 2024
POPULAR